Hile Bio director plans share reduction

Shanghai Hile Bio-Technology (SSE:603718) announced that director and general manager Han Benyi plans to reduce his stake in the company. Han, who currently holds 3,000,000 shares (0.4560% of the total share capital), intends to reduce his holding by no more than 750,000 shares (0.1140% of the total share capital). The sales will be carried out via a centralized bidding method between March 14, 2025, and June 13, 2025, at market prices prevailing at the time of the transactions. The planned reduction is due to Han's personal financial requirements. The company stated that the reduction plan aligns with relevant laws and regulations and that they will fulfill information disclosure obligations promptly.